The genetic changes of hepatoblastoma
H Chen, Q Guan, H Guo, L Miao, Z Zhuo - Frontiers in oncology, 2021 - frontiersin.org
Hepatoblastoma is the most common malignant liver cancer in childhood. The etiology of
hepatoblastoma remains obscure. Hepatoblastoma is closely related to genetic syndromes …
hepatoblastoma remains obscure. Hepatoblastoma is closely related to genetic syndromes …
Epigenetics and genetics of hepatoblastoma: linkage and treatment
L Zhu, W Zheng, Q Gao, T Chen, Z Pan, W Cui… - Frontiers in …, 2022 - frontiersin.org
Hepatoblastoma is a malignant embryonal tumor with multiple differentiation modes and is
the clearest liver malignancy in children. However, little is known about genetic and …
the clearest liver malignancy in children. However, little is known about genetic and …
Genetics and epigenetics of hepatoblastoma
GE Tomlinson, R Kappler - Pediatric blood & cancer, 2012 - Wiley Online Library
A number of unique genetic features are observed in hepatoblastoma that have provided
insights into the origins of hepatoblastoma. Hallmark cytogenetic changes in …
insights into the origins of hepatoblastoma. Hallmark cytogenetic changes in …
The genetic and epigenetic landscapes of hepatoblastomas
Primary liver cancers are rare in children, and the most common type is hepatoblastoma
(HB), an embryonal tumor with histological features that resemble different stages of liver …
(HB), an embryonal tumor with histological features that resemble different stages of liver …
Whole-genome sequencing and RNA sequencing analysis reveals novel risk genes and differential expression patterns in hepatoblastoma
W Wang, N Zhang, L Chen, X Zhao, Y Shan, F Yang… - Gene, 2024 - Elsevier
Hepatoblastoma (HB) is an uncommon malignant liver cancer primarily affecting infants and
children, characterized by the presence of tissue that resembling fetal hepatocytes, mature …
children, characterized by the presence of tissue that resembling fetal hepatocytes, mature …
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
J Carrillo-Reixach, L Torrens, M Simon-Coma… - Journal of …, 2020 - Elsevier
Background & Aims Hepatoblastoma (HB) is a rare disease. Nevertheless, it is the
predominant pediatric liver cancer, with limited therapeutic options for patients with …
predominant pediatric liver cancer, with limited therapeutic options for patients with …
[引用][C] Unravelling the genetics of hepatoblastoma: few mutations, what else?
MA Buendia - Journal of Hepatology, 2014 - journal-of-hepatology.eu
Among different types of primary liver cancer, hepatoblastoma (HB) has singular clinical,
pathological and biological characteristics that deserve closer attention. This rare paediatric …
pathological and biological characteristics that deserve closer attention. This rare paediatric …
[PDF][PDF] Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups
P Sumazin, Y Chen, LR Treviño, SF Sarabia… - …, 2017 - Wiley Online Library
Despite being the most common liver cancer in children, hepatoblastoma (HB) is a rare
neoplasm. Consequently, few pretreatment tumors have been molecularly profiled, and …
neoplasm. Consequently, few pretreatment tumors have been molecularly profiled, and …
Genetic changes in hepatoblastoma
SF Ding, NE Michail, NA Habib - Journal of hepatology, 1994 - Elsevier
Hepatoblastoma is a rare cancer, but it is the most common primary malignant hepatic
tumour in childhood, accounting for 71-75/,, of liver cancers (1, 2). The environmental risk …
tumour in childhood, accounting for 71-75/,, of liver cancers (1, 2). The environmental risk …
Unraveling the genetic architecture of hepatoblastoma risk: birth defects and increased burden of germline damaging variants in gastrointestinal/renal cancer …
The ultrarare hepatoblastoma (HB) is the most common pediatric liver cancer. HB risk is
related to a few rare syndromes, and the molecular bases remain elusive for most cases. We …
related to a few rare syndromes, and the molecular bases remain elusive for most cases. We …